Absci Corporation (ABSI) vs Novavax, Inc. (NVAX)

A side-by-side comparison of Absci Corporation and Novavax, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ABSI vs NVAX

growth of $100 · dividends reinvested · last 5y
ABSI -46.6% (-11.8%/yr)NVAX -93.2% (-41.6%/yr)ABSI compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$53$7
ABSI NVAX

ABSI vs NVAX: by the numbers

  • •NVAX is the larger company ($1.82B vs $1.78B market cap).
  • •Both run net losses; NVAX's is the smaller (-59.87% vs -7756.37% net margin).
  • •NVAX grew revenue faster over the past five years (118.86% vs -22.08% CAGR).

Metrics side by side

Valuation

MetricABSINVAX
P/S ratio1140.854.39
P/B ratio7.24N/A

Profitability

MetricABSINVAX
Gross margin-319.36%93.67%
Operating margin-4454.21%50.14%
Net margin-7756.37%-59.87%
ROE-49.19%N/A
ROIC-52.66%-36.37%

Growth (annualized)

MetricABSINVAX
Revenue CAGR (5Y)-22.08%118.86%
Total return CAGR (5Y)0.89%-40.61%

Frequently asked

Which has grown faster, ABSI or NVAX?
Over the past five years, NVAX grew revenue faster — ABSI at a -22.08% CAGR versus NVAX at 118.86%.
How have ABSI and NVAX total returns compared?
Over the past 5 years, ABSI delivered 0.89% and NVAX delivered -40.61% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.